U.S. Semiconductors Stock News

Corporate governance changes and rising ESG tension at Skyworks Solutions (SWKS) Skyworks Solutions (SWKS) is in focus after proposing Charter amendments to remove supermajority voting provisions, while simultaneously facing an ESG related shareholder proposal on greenhouse gas reporting that the Board has urged investors to vote against. See our latest analysis for Skyworks Solutions. The governance and ESG debates arrive as the stock trades at US$55.19, with a 1-day share price return of...

SharkNinja stock overview SharkNinja (SN) has drawn fresh attention after recent trading left the shares with a month return of about an 8% decline and a past 3 months return near an 8% decline. Over the past year, the stock shows a total return close to 49%, while shorter term moves have been more mixed, inviting a closer look at how the company’s fundamentals line up with recent price action. See our latest analysis for SharkNinja. Recent trading has been choppy, with a 1 day share price...

Aon (AON) has updated its Radford McLagan Compensation Database to include AI specific job families and real time decision tools, responding to rising demand for AI talent and sharper pay transparency. See our latest analysis for Aon. Despite the AI-focused product updates and other recent developments, including funding activity in health technology and new leadership appointments, Aon’s 1-year total shareholder return decline of 13.27% and 3-month share price return decline of 6.14%...

Why Kiniksa Pharmaceuticals International (KNSA) just moved onto investors’ radar Recent analysis points to Kiniksa Pharmaceuticals International (KNSA) reaching an important phase, with earnings and revenue growth supporting a transition toward profitability while the share price trades close to its 52 week high. See our latest analysis for Kiniksa Pharmaceuticals International. The recent move to a 1 day share price return of 1.43% and a year to date share price return of 16.22% comes on...

CenterPoint Energy recently outlined a decade-long US$65.50 billion grid modernization plan and held a Connected Worker: Energy Summit presentation in Houston, while also preparing to report its Q1 2026 earnings on April 23. Together, the large-scale infrastructure investments, upcoming earnings release, and evolving customer programs highlight how CenterPoint is reshaping its role in meeting growing power demand and reliability expectations. We’ll now examine how this large grid...

For investors wondering whether Barrick Mining still offers value after a strong run, or if the easy gains are already behind it, this article focuses on what the current share price might be implying. The stock last closed at US$41.64, with a 7-day return of 7.9%, a 30-day return decline of 8.2%, a year-to-date return decline of 5.5%, and a 1-year return of 141.3%. Recent headlines around Barrick Mining have kept attention on the stock, as investors consider how company-specific...

Lumentum Holdings (LITE) is back in focus after securing a multi billion dollar investment and purchase commitments from Nvidia, alongside acquiring a 240,000 square foot US fab to expand AI focused optical manufacturing. See our latest analysis for Lumentum Holdings. The stock’s recent run has been powerful, with an 8.14% 1 day share price return, 27.05% 30 day share price return, and 114.16% year to date share price return. The 1 year total shareholder return is extremely high, suggesting...

On April 1, 2026, Vir Biotechnology director Vicki Sato sold 22,000 shares under a Rule 10b5-1 plan, following a year of sustained insider selling and no insider purchases. This selling activity comes shortly after Vir Biotechnology raised about US$172.5 million in a public offering, alongside growing analyst focus on its Astellas prostate cancer collaboration. We will now examine how the recent insider sale, coming soon after the capital raise, may influence Vir Biotechnology’s investment...

Stock performance snapshot and recent context Herbalife (HLF) has moved sharply over different time frames, with a 3.5% decline over the past day, a 3.6% decline over the past week, a 14.2% decline over the past month, and an 8.3% gain over the past 3 months. Over longer horizons, the stock shows a 67.9% total return over the past year, alongside total return declines of 11.4% over three years and 69% over five years. This highlights mixed outcomes for different entry points. See our latest...

Recently, RPC, Inc. reported weaker-than-expected fourth-quarter and full-year 2025 results, including an 18% sequential decline in Support Services revenue driven by a 22% drop in rental tools demand, prompting a securities fraud investigation by the Portnoy Law Firm. At the same time, easing geopolitical tensions between the U.S. and Iran pushed crude prices lower, weighing on oilfield services sentiment and compounding concerns already raised by RPC's softer Support Services...

Why GigaCloud Technology Is Back on Investors’ Radar GigaCloud Technology (GCT) is drawing fresh attention after analysts lifted earnings estimates and highlighted its track record versus forecasts, alongside recent moves to expand in Europe and grow its US distribution footprint. See our latest analysis for GigaCloud Technology. Those upgrades in earnings estimates and recent expansion moves come against a backdrop of a 15.5% year to date share price return and a very large 3 year total...

Lufax Holding is now the target of multiple securities class action lawsuits in the US, following allegations of inadequate internal controls, undisclosed related-party transactions, and materially misstated financial results, as well as the removal of auditor PricewaterhouseCoopers over concerns about its 2022 and 2023 reports. An unusual aspect of this situation is the rare withdrawal of PwC’s prior audit opinions, prompting several law firms to pursue claims on behalf of investors who...

Belite Bio (BLTE) drew attention after its Phase 3 DRAGON trial met the primary endpoint for Tinlarebant, alongside a US$402 million public offering that supports its planned NDA submission and early commercialization work. See our latest analysis for Belite Bio. The trial success and funding news sit against a share price of US$169.85, with a 7 day share price return of 11.69% but a 30 day share price return decline of 1.58%. The 1 year total shareholder return of 198.51% and 3 year total...

Analog Devices (ADI) is back in focus after its industrial division reported 38% year over year growth and strong demand for AI chip testing equipment, alongside positive analyst commentary on the stock. See our latest analysis for Analog Devices. Recent enthusiasm around the industrial growth story and bullish analyst commentary has come alongside a 90 day share price return of 16.29%, contributing to a 1 year total shareholder return of 96.35%. This indicates strong momentum following a...

A recent analyst report spotlighting Columbia Sportswear (COLM) for its strong value grade and valuation ratios below industry averages has put fresh attention on the stock, especially given the reference to a positive earnings outlook. See our latest analysis for Columbia Sportswear. Despite the recent focus on attractive valuation metrics, Columbia Sportswear’s recent price action has been weak, with a 1 month share price return decline of 9.34% and a 1 year total shareholder return decline...

Carnival Corporation & (CCL) is back in the spotlight after reporting record first quarter revenue, outlining its new PROPEL multi year plan, and authorizing a US$2.5b share repurchase alongside lower full year earnings guidance. See our latest analysis for Carnival Corporation &. The share price has pulled back recently, with a 1 day share price return of a 3.54% decline and a 90 day share price return of a 17.08% decline. This comes even as the 1 year total shareholder return of 56.11% and...

Evercore stock snapshot after recent performance swings Evercore (EVR) has seen mixed share price performance recently, with a 1.2% move over the past day, around 9.3% over the past week, and small declines over the past month and past three months shaping short-term sentiment. See our latest analysis for Evercore. That recent 9.3% 7 day share price gain comes after a weaker year to date share price return of a 13.2% decline. However, longer term total shareholder returns above 150% over...

Why Vulcan Materials Stock Is Back in Focus After New 2026 Guidance Vulcan Materials (VMC) is back on investors' radar after management issued 2026 guidance calling for modest growth in aggregate shipments and adjusted EBITDA, despite missing Q4 2025 earnings estimates. See our latest analysis for Vulcan Materials. After a sharp reaction to the Q4 2025 earnings miss and record-volume moves around the 2026 guidance announcement, Vulcan Materials now trades at US$279.88, with a 7.05% 7 day...

In March 2026, Banco Santa Cruz announced it had migrated from its legacy system to FICO Platform’s cloud-native decisioning capabilities on AWS, enabling real-time, PCI-compliant credit decisions across mobile, branch, and online channels. This deployment highlights how FICO’s platform can underpin a customer-centric origination model, with champion-challenger testing, automated governance, and scalable multi-product support for cards, personal loans, mortgages, and auto lending. We’ll now...

Context on Atkore’s recent share performance Atkore (ATKR) has drawn investor attention after a period of mixed share performance, with gains over the past year contrasting with negative returns in the past month and over the past 3 months. See our latest analysis for Atkore. Recent trading reflects this tension, with a 1-day share price return of 2.11% and a 7-day share price return of 4.03% contrasting with a 1-year total shareholder return of 16.14%. The 3-year total shareholder return...

Executive change triggers fresh look at Ardent Health stock Ardent Health (ARDT) shares are in focus after the company announced that Ethan Chernin, President of Hospital Services, departed on March 24, 2026, under its executive severance plan, prompting investors to reassess leadership stability and valuation. See our latest analysis for Ardent Health. With the latest close at $8.66, Ardent Health has seen a 1 month share price return of 8.26% decline and a 1 year total shareholder return of...

Core Natural Resources recently reported past Q4 results showing revenue up 81.8% year on year and an EBITDA outcome that exceeded analyst expectations, while also resuming longwall mining at its Leer South mine following earlier operational challenges. At the same time, the company faces pressure from lower 2026–2027 earnings estimates and ongoing headwinds for coal demand as energy policies and renewables adoption advance. Against this backdrop, we'll examine how the EBITDA beat and...

Applied Industrial Technologies (AIT) has been in focus after acquiring Thompson Industrial Supply. This event is expected to add meaningful annual revenue, while the core Service Center distribution segment reports steady demand and organic sales growth. See our latest analysis for Applied Industrial Technologies. While the share price has eased slightly in the past month, with a 30 day share price return of a 2.85% decline, the 1 year total shareholder return of 27.62% and 5 year total...

In March 2026, Beyond Meat reported fourth-quarter 2025 results showing sales falling to US$61.59 million from US$76.66 million a year earlier, while a shift to net income of US$409.85 million and guidance for first-quarter 2026 revenues of US$57 million to US$59 million highlighted weaker demand and softer near‑term expectations. The company also disclosed material weaknesses in inventory accounting, delaying its annual filing and adding governance and reliability concerns to already...